Targeting SLC39A14 with miR-875-3p enhanced migration and invasion capabilities of osteosarcoma cells.
The study suggests targeting the miR-875-3p/SLC39A14 axis for potential therapeutic interventions.
Abstract
miR-875-3p promotes osteosarcoma progression by targeting SLC39A14 and suppressing ferroptosis, suggesting the miR-875-3p/SLC39A14 axis as a potential therapeutic target for osteosarcoma treatment.